Another study by Lian et al. also reported that miR-128 directly targeted SIRT1 to regulate the resistance of CRC cells towards tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) which is an anti-cancer agent [30]. This evidence concerns the gene SIRT1 and colorectal carcinoma.